Tagged Articles

uterine sarcoma 64 articles

Physician-advocates speak out about dangers of power morcellation

Husband-and-wife physicians Amy Reed and Hooman Noorchashm are taking the leadership of the American College of Obstetrics (ACOG) and other well-decorated gynecologists to task in their latest opinion piece published in Philly.com. The couple have been advocating for the ban of power morcellation for hysterectomies and myomectomies (uterine fibroid removal) because the devices can spread undiagnosed uterine cancer, worsening the odds of survival. Reed and Noorchashm are all too familiar with the issue. Reed underwent a hysterectomy during which a power morcellator was used. The device consists of a tube-like blade that shreds uterine growths or entire uteruses within the ... Read More

Decrease in power morcellation but not in cases of uterine cancer

The use of power morcellators for hysterectomies or myomectomies (uterine fibroid removal) decreased dramatically after the Food and Drug Administration (FDA) warned that the procedure could spread undiagnosed uterine cancer in women, worsening their odds of survival. But the rate of uterine cancer in women who underwent procedures with power morcellators increased, according to a review of a national database. Power morcellators are surgical tools fitted with tube-like blades that mince uterine growths or entire uteruses within the body and remove the tissue through a small incision in the abdomen. The procedure is less invasive, and offers less risk for ... Read More

Power morcellator victims fight for patient safety

“Congress and the American people need to know that our public safety laws mean something – and that hospitals and manufacturers are aware that complacency in protecting patients has legal consequences.” The statement was made in a Philadelphia Inquirer editorial written by husband and wife Drs. Amy Reed and Hooman Noorchashm. The couple has become patient advocates pressing lawmakers to enact stiffer rules governing medical devices in the name of patient safety. In 2013, at the age of 43, Reed, an anesthesiologist and mother of six, had a hysterectomy to resolve problems from what doctors assumed were benign uterine fibroids. ... Read More

Lawsuits target makers of power morcellators due to cancer spread risk

Dozens of lawsuits have been filed against the makers of a surgical tool used during gynecological surgeries, alleging the devices have caused undiagnosed uterine cancers to spread aggressively, worsening the odds of survival. The device, known as a power morcellator, is used to perform laparoscopic hysterectomies and myomectomies (uterine fibroid removal). It is fitted with a tube-like blade that minces uterine growths or entire uteruses inside the body and then removes the tissue through a small incision in the abdomen. Power morcellation procedures have been favored over open surgeries because they are less invasive, leave less scar tissue, and offer ... Read More

FDA investigating why hospitals did not report cancer risks with power morcellators

The Food and Drug Administration (FDA) has conducted investigations of several hospitals to find out why doctors and administrators did not report patient injuries and deaths caused by complications for gynecological procedures using power morcellator devices. Under the Code of Federal Regulations, manufacturers of medical devices and hospitals are required to report to the FDA within 10 to 30 days adverse outcomes such as serious injuries and deaths that a medical device may have caused or contributed to. But in the case of power morcellators, this required reporting system appears to have failed. Power morcellators are surgical tools that shred ... Read More

FDA approves new power morcellator containment system

The Food and Drug Administration (FDA) has approved the first tissue containment system for use with certain laparoscopic power morcellators used to perform hysterectomies and uterine fibroid removals. The system is designed to isolate uterine tissue that is not suspected to contain cancer. However, the FDA’s approval requires makers of the PneumoLiner to warn patients that the containment system has not been proven to reduce the risk of cancer spread during power morcellation procedures. Power morcellators are surgical tools fitted with tube-like blades that mince entire uteruses or uterine growths within the body and remove the tissue through small incisions ... Read More

Study links power morcellation to higher death risk in uterine cancer patients

The risk for early recurrence of uterine sarcoma – a rare type of uterine cancer – is higher and the chance for early survival is lower in women who have undergone hysterectomies using power morcellation devices, according to a new study published in Medscape. Power morcellation uses a laparoscopic surgical tool fitted with a tube-like blade that minces uterine growths or entire uteruses within the body and removes the tissue through a small incision in the abdomen. It has been used in some women for hysterectomies and myomectomies (uterine fibroid removal) over open surgeries because of benefits such as shorter recovery ... Read More

Power morcellation still being offered despite risk of cancer spread

In November 2014, the Food and Drug Administration (FDA) placed a black box warning on power morcellators used to perform hysterectomies and myomectomies (uterine fibroid removals) alerting physicians that the surgical tools could spread previously undetected uterine cancer, worsening a woman’s odds of survival. “Despite this, there are doctors who suspect that their patients may in fact have cancer and are still recommending robotic procedures using a power morcellator to perform hysterectomies,” The Center for Innovative GYN Care cautioned. Power morcellators are surgical tools fitted with a long, tube-like blade that minces uterine fibroids or entire uteruses within the uterine cavity ... Read More

Three lawyers withdraw from power morcellator MDL steering committee

Three attorneys have withdrawn from the 20-person plaintiff leadership team in the multidistrict litigation (MDL) over power morcellators made by Johnson & Johnson’s Ethicon Inc., over disagreements with legal fees and costs. The MDL steering committee, appointed by U.S. District Judge Kathryn Vratil of Kansas, was recognized as the first to be made up of a majority of women, a seemingly obvious idea considering the power morcellation complaints directly affect women. The resignations leave only 10 women on the now-17-person committee. The lawyers took issue with requirements that they should pay into a proposed common benefit fund for cases they had ... Read More

Doctors petition FDA to loosen power morcellator restrictions

Nearly four dozen physicians signed an open letter to the Food and Drug Administration (FDA) urging the agency to rethink its decision to place restrictions on power morcellator devices used to perform hysterectomies and myomectomies (uterine fibroid removals), and empower women with the freedom to make their own decisions with their surgeons as to which procedure is right for them. “I think physicians should understand that there is certainly a safety concern with morcellation and they need to use caution to minimize the risk of inadvertently morcellating a precancerous or cancerous lesion,” said Dr. Jason Wright, with the Columbia University ... Read More